LACTULOSE
End Stage Liver DIsease
Bogomolets National Medical UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the End Stage Liver DIsease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Giapreza University of California, Los Angeles | Phase 4 | BB |
Noradrenaline University of California, Los Angeles | Phase 4 | BB |
Genotropin Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 2/3 | B |
Ribavirin Gilead Sciences | Phase 2 | B |
Sofosbuvir Gilead Sciences | Phase 2 | B |
View all 10 →
Same molecule, other indications
LACTULOSE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →